RightEye Enters Into Agreement With MIT to Research Ocular Biomarker 'Signature' for Lyme Disease BETHESDA, Md., April 25, 2022 (GLOBE NEWSWIRE) -- RightEye, the world's leading eye-tracking biomarker company, has signed a research collaboration agreement with the Massachusetts Institute of...

Oculogica’s New Patent Opens Potential for a CTE Test for Live Subjects NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) -- Oculogica, a leader in concussion diagnosis and categorization, with the only FDA-cleared technology that aids in the diagnosis of concussion without the...

Ocutrx Sets the Pace for AR Medical Device Technology at Third Annual Medical Devices Innovation Conference IRVINE, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, an advanced research and development California-based manufacturer of augmented reality (AR) glasses, is pleased to...

Dr. Thomas A. Finley, M.D. Appointed as Chairmen of Ocutrx International Medical Advisory Board IRVINE, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California based Augmented Reality (AR) Glasses developer today announced that Dr. Thomas A. Finley, M.D. will...

First Medical Patent Issued for the Oculenz™ Augmented Reality Glasses IRVINE, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, a California based Augmented Reality (AR) Glasses developer today announced that the company’s core AR medical...